Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hepatectomy, Analgesia or Nerve Block
and you are
between 18 and 70
years old
The phase for this study is not defined.
Show me locations

The purpose

This prospective, randomized study, control study aims to compare the analgesic effect, opioids consumption, quality of recovery, length of hospital stay and et al. between unilateral continuous quadratus lumborum block (QLB) and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing hepatectomy with right J-shape subcostal incision.

Provided treatments

  • Procedure: Continous QLB (quadratus lumborum block)
  • Device: Philip CX50 Ultrasound Scanner
  • Device: PAJUNK Contiplex S Catheter
  • Drug: Ropivacaine
  • Drug: Morphine given as IPCA
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02914015. The sponsor of the trial is Cui Xulei and it is looking for 62 volunteers for the current phase.
Official trial title: